$BHC.TSX Q2 '26 Earnings Results & Recap
Bausch Health Companies Inc. raised its full-year 2026 guidance, targeting consolidated revenue of $10.790-$11.040 billion and adjusted EBITDA of $4.050-$4.175 billion, reflecting strong momentum across its core business segments.